WHO Model Prescribing Information: Drugs Used in Skin Diseases
(1997; 132 pages) [French] [Spanish] Ver el documento en el formato PDF
Índice de contenido
Ver el documentoPreface
Ver el documentoIntroduction
Abrir esta carpeta y ver su contenidoParasitic infections
Abrir esta carpeta y ver su contenidoInsect and arachnid bites and stings
Abrir esta carpeta y ver su contenidoSuperficial fungal infections
Abrir esta carpeta y ver su contenidoSubcutaneous fungal infections
Abrir esta carpeta y ver su contenidoBacterial infections
Abrir esta carpeta y ver su contenidoViral infections
Abrir esta carpeta y ver su contenidoEczematous diseases
Cerrar esta carpetaScaling diseases
Ver el documentoIchthyosis
Ver el documentoXerosis
Abrir esta carpeta y ver su contenidoPapulosquamous diseases
Ver el documentoCutaneous reactions to drugs
Abrir esta carpeta y ver su contenidoPigmentary disorders
Abrir esta carpeta y ver su contenidoPremalignant lesions and malignant tumours
Abrir esta carpeta y ver su contenidoPhotodermatoses
Abrir esta carpeta y ver su contenidoBullous dermatoses
Ver el documentoAlopecia areata
Ver el documentoUrticaria
Abrir esta carpeta y ver su contenidoConditions common in children
Ver el documentoAcne vulgaris
Ver el documentoPruritus
Ver el documentoTropical ulcers
Abrir esta carpeta y ver su contenidoAntimicrobial drugs
Abrir esta carpeta y ver su contenidoAntifugal drugs
Abrir esta carpeta y ver su contenidoAntiseptic agents
Abrir esta carpeta y ver su contenidoKeratoplastic and keratolytic agents
Abrir esta carpeta y ver su contenidoScabicides and pediculicides
Abrir esta carpeta y ver su contenidoAnti-inflammatory and antipruritic drugs1
Abrir esta carpeta y ver su contenidoAntiallergics and drugs used in anaphylaxis
Abrir esta carpeta y ver su contenidoUltraviolet radiation-blocking agents (sunscreens)
Abrir esta carpeta y ver su contenidoMiscellaneous drugs
Abrir esta carpeta y ver su contenidoAnnex
Ver el documentoSelected WHO Publications of Related Interest
Ver el documentoBack cover
 

Xerosis

Xerosis, or dryness of the skin, is the most common form of fine scaling seen, particularly among children and the elderly. It is usually accompanied by mild or severe pruritus and is exacerbated by environmental factors such as exposure to sunlight. In the elderly, xerosis may cause atrophoderma.

Treatment

Every effort should be made to keep the skin moist. Detergents and other degreasing agents should therefore be avoided.

Baths should be tepid rather than hot, and soap should be used sparingly. In cold climates, adequate protective clothing should be worn in cold weather, and in centrally heated premises, efforts should be made to humidify the air.

Emollients such as aqueous creams and emulsifying ointments should be applied once or twice daily to affected skin in severe cases. The addition of a keratolytic agent, such as 1-5% salicylic acid or 5% lactic acid, can be helpful. Salicylic acid should be used sparingly in children because of the risk of systemic salicylism. Occlusion therapy using a 60% aqueous solution of propylene glycol may be effective in unresponsive cases where circumstances permit, but cannot be used in warm or hot climates since it may cause thermoregulatory problems and increase the risk of secondary infection. An aqueous cream containing 10% urea, which has moisturizing, keratolytic and antimitotic properties, may prove more effective than an emulsifying ointment. Sodium chloride, 0.9% solution, is sometimes added to increase the moisturizing effect. α-Hydroxy acids such as pyruvic acid and glycolic acid in concentrations of 0.5-2% have been introduced recently and appear to be useful, particularly in xerosis.

Topical or systemic administration of retinoids may be of value in certain rare forms of ichthyosis in which the hyperkeratosis is caused by hyperproliferation rather than defective desquamation. However, the improvement induced by therapy may not persist after the drug is stopped, and long-term treatment may be necessary.

 

Ir a la sección anterior Ir a la siguiente sección
 

Última actualización: le 24 abril 2012